J. Kneer

发表

Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants

W. Hayton, J. Kneer, R. de Groot, 1996, Antimicrobial agents and chemotherapy.

Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs

Malcolm Rowland, Johannes Kneer, M. Rowland, 2006, Clinical pharmacology and therapeutics.

Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children

W. Hayton, J. Kneer, K. Stoeckel, 1991, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review.

J. Kneer, K. Stoeckel, Y. Tam, 1989, Current medical research and opinion.

Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects

R. Blouin, J. Kneer, K. Stoeckel, 1989, Antimicrobial Agents and Chemotherapy.

The intravitreal penetration of ceftriaxone in man following systemic administration.

J. Kneer, E. Rubinstein, M. Sharir, 1989, Investigative ophthalmology & visual science.

Selective Screening for Organic Acidurias in the Federal Republic of Germany

J. Kneer, W. Lehnert, H. Niederhoff, 1984 .

Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys.

Johannes Kneer, Yvonne S. Lin, J. Kneer, 2007, Glycobiology.

Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers

U. Dubach, J. Kneer, K. Stoeckel, 1990, Antimicrobial Agents and Chemotherapy.

Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy.

J. Kneer, K. Stoeckel, D. Edwards, 1992, International journal of antimicrobial agents.

Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil

R. Blouin, J. Kneer, K. Stoeckel, 1990, Antimicrobial Agents and Chemotherapy.

The first adult case with 4-hydroxybutyric aciduria

K. Gibson, J. Kneer, C. Jakobs, 1990, Journal of Inherited Metabolic Disease.

In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: Limited diagnostic use of 1-13C fatty acid breath test using bolus technique

B. Poll-The, J. Saudubray, J. Kneer, 1997, European Journal of Pediatrics.

Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age—part 1

J. Kneer, C. Jakobs, E. Mönch, 2005, European Journal of Pediatrics.

4-Hydroxybutyric aciduria: A new inborn error of metabolism. I. Clinical review

F. Hanefeld, P. Divry, D. Rating, 1984, Journal of Inherited Metabolic Disease.

Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.

M. Koulu, J. Kneer, A. Korn, 1996, Clinical neuropharmacology.

(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase.

J. Kneer, D. Walter, R. Devos, 2002, The Journal of pharmacology and experimental therapeutics.

Bioavailability and feasibility of subcutaneous 5-fluorouracil.

J. Kneer, K. Brunner, T. Cerny, 1993, British Journal of Cancer.

13C-ethanol and 13C-acetate breath tests in normal and aldehyde dehydrogenase deficient individuals.

W. Lehmann, D. Rating, J. Kneer, 1986, Alcohol.

In Vivo Study of Phytanic Acid α-Oxidation in Classic Refsum's Disease and Chondrodysplasia Punctata

H. J. Brink, B. Poll-The, J. Saudubray, 1992, Pediatric Research.

Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.

J. Kneer, H. Groen, J. Dingemanse, 1995, Journal of clinical psychopharmacology.

Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis

R. Blouin, W. Hayton, J. Kneer, 1990, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency

F. Frey, R. Blouin, J. Kneer, 1989, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers

U. Dubach, J. Kneer, K. Stoeckel, 1989, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic properties of new oral cephalosporins

J. Kneer, 1992 .

Lethal hyperammonaemic coma due to ornithine transcarbamylase deficiency presenting as brain stem encephalitis in a previously asymptomatic ten-year-old boy

T. Coşkun, J. Kneer, S. Mönch, 1987, Journal of Inherited Metabolic Disease.

Relevance of antibiotic tissue penetration in treating respiratory tract infections.

J. Kneer, 1993, Respiration; international review of thoracic diseases.

Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.

H. Paulus, M. Weisman, D. Furst, 2003, Journal of Rheumatology.

In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: Limited diagnostic use of 1- 13 C fatty acid breath test

J. Saudubray, J. Kneer, C. Jakobs, 1997 .

Determination of the retinoid (E)-1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2- phenylethenyl)naphthalene and its phenolic metabolite in human plasma by reversed-phase high-performance liquid chromatography.

J. Kneer, K. Rissler, G. Friedrich, 1991, Journal of chromatography.

Determination of Midazolam and Its α‐Hydroxy Metabolite in Human Plasma and Urine by High‐Performance Liquid Chromatography

K. Rentsch, J. Kneer, H. Ha, 1993, Therapeutic drug monitoring.